Quanome CEO to Back Quantum Strategy with Up to $15 Million in Non-Dilutive Growth Capital

Each borrowing requires the CEO's approval, and approved advances carry 6.0% annual interest without issuing equity.

Rhea-AI Summary

Quanome Technologies (Nasdaq: QNME) entered into a revolving loan agreement with CEO and Chairman Yang Li for up to $15 million. The arrangement provides a potential source of non-dilutive growth capital for its quantum-focused priorities. Approved advances bear interest at 6.0% per annum. Repaid amounts may be borrowed again during the draw period, subject to repayment terms and Li's approval of each borrowing request. Proceeds will fund working capital and general corporate purposes.

The Board's Audit Committee independently reviewed and approved the transaction. Quanome's strategy covers Quantum and AI Systems, Quantum Life Sciences - Molecular Discovery, Advanced Nuclear, and Quantum-Safe Cybersecurity. It is developing its XDT AI cloud business and recently announced an infrastructure purchase agreement as an initial step toward a planned first U.S. AI infrastructure hub.

4 points · 1 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

1 major · 2 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Major point. Forward-looking: it has not happened yet and may not happen.Up to $15 million in non-dilutive growth capital provides Quanome an additional potential funding source. 82% of market cap
• Minor pointRevolving structure permits repaid amounts to be borrowed again during the draw period.
• Minor point. Forward-looking: it has not happened yet and may not happen.Infrastructure purchase agreement marks an initial step toward Quanome's planned first U.S. AI infrastructure hub.
• Minor pointXDT AI cloud business is under development within Quanome's Quantum and AI Systems strategy.

Negative

• Major point. Forward-looking: it has not happened yet and may not happen.Approved loan advances add debt bearing interest at 6.0% per annum.
• Minor pointEach borrowing request requires Li's approval; repeat borrowing is also subject to the agreement's repayment terms.

Argus 15 min delay 29 alerts

+2.63% vs previous close $0.55 last price 104.9x rel. volume Open Argus

Details

Market Reaction – QNME

+8.4% Peak in 5 min

$0.52 – $1.02 Day Range

$18.80M Market Cap

On Oct 1, the day this news came out, the latest delayed price for QNME is 2.63% above the previous close. Argus tracked a peak move of +8.4% during the session. Our momentum scanner has recorded 29 alerts for this stock so far that day. The latest delayed price is $0.55. Relative volume is exceptionally heavy at 104.9x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Maximum loan amount: Up to $15 million Interest rate: 6.0% per annum

Maximum loan amount

Up to $15 million

Revolving growth-capital loan from the CEO and Chairman

Interest rate

6.0% per annum

Applies to approved advances

Key Terms

revolving loan, non-dilutive

2 terms

revolving loan financial

"has entered into a revolving loan agreement"

A revolving loan is a credit line a company can draw, repay, and draw again up to a set limit during the loan term — like a corporate credit card where interest is charged only on the amount used. It matters to investors because it supplies flexible short-term cash for operations or growth but can raise borrowing costs and leverage; reductions in the available limit or tighter terms can signal liquidity stress or increase financial risk.

non-dilutive financial

"for up to $15 million in non-dilutive growth capital"

Non-dilutive describes funding or income that does not reduce existing shareholders’ ownership percentage. It matters to investors because it lets a company raise money or generate value—through grants, loans, licensing deals, or revenue—without issuing extra shares, so each existing share keeps the same claim on profits and control; think of adding toppings to a cake without cutting it into more slices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Insider Scaled Capital Support Reflects Confidence
in Quanome's Strategic Direction and Future Potential

NEW YORK, NY, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Quanome Technologies, Inc. (Nasdaq: QNME) ("Quanome" or the "Company"), has entered into a revolving loan agreement with the Company’s CEO and Chairman, Yang Li, for up to $15 million in non-dilutive growth capital.  The arrangement gives Quanome an additional potential source of capital as it executes its strategic priorities in the quantum computing space.

Approved advances will bear interest at 6.0% per annum. The instrument is revolving, meaning amounts repaid may be borrowed again during the draw period, subject to the agreement's repayment terms and Mr. Li’s approval of each borrowing request. Any proceeds will be used for working capital and general corporate purposes.

The transaction was reviewed and approved independently by the Audit Committee of Quanome's Board of Directors. The committee determined that the agreement and the transactions it contemplates are fair and reasonable to the Company and in, or not inconsistent with, the best interests of the Company and its stockholders. Mr. Li disclosed his interest and did not participate in the Audit Committee’s deliberations or vote.

"I am deeply committed to Quanome's quantum-focused strategy and the long-term potential of the growth opportunities we are pursuing,” said Yang Li, Chief Executive Officer and Chairman of Quanome Technologies. “Providing this financial support is a practical expression of my confidence in our future. Our ambition remains steadfast: to connect quantum science, artificial intelligence and advanced computing with real-world applications that can create tangible social and economic value for communities and economies, world-wide."

Quanome's strategy spans four streams: Quantum and AI Systems, Quantum Life Sciences - Molecular Discovery, Advanced Nuclear, and Quantum-Safe Cybersecurity. Within Quantum and AI Systems, Quanome is developing XDT, its AI cloud business. The Company recently announced an infrastructure purchase agreement as an initial step toward its planned first U.S. AI infrastructure hub. These initiatives support Quanome's broader aim of making advanced technologies more accessible and leveraging them into practical applications for potential long-term economic and societal benefits.

Quanome's Global Quantum Council and Scientific Advisory Network are also intended to bring scientific, technological and commercial perspectives together for broader market benefit. The Company aims to link with experts in quantum and related complex sciences to help provide insights on trends, as well as evaluate emerging technologies, collaborations and opportunities that provide practical growth and potential.

ENDS

NOTES FOR EDITORS

Media / Investor Relations Contact:
Lauren Callie
www.Quanometech.com
investor@Quanometech.com

Editors Notes

About Quanome Technologies

Quanome Technologies, Inc. (Nasdaq: QNME) is a U.S.-based technology company focused on opportunities across Quantum and AI Systems, Quantum Life Sciences - Molecular Discovery, Advanced Nuclear, and Quantum-Safe Cybersecurity. The Company combines commercial initiatives with the development of a global scientific network through its Global Quantum Council and Scientific Advisory Network. Quanome aims to translate advances in quantum science and related technologies into practical, real-world applications across industries shaped by complex computational and scientific challenges.

Forward-Looking Statements

This release contains forward-looking statements regarding potential loan advances under the revolving loan agreement, the anticipated use and benefits of any proceeds, the Company's financial flexibility and strategic priorities, the evaluation and development of quantum-related technologies, potential commercial opportunities, future partnerships and collaborations, and the Company's strategy and future operations. These statements are based on current plans, assumptions and expectations and involve risks and uncertainties. Actual results and timing may differ materially, including because each loan advance requires the lender's approval and is subject to the agreement's conditions, and due to financing availability, technological and competitive developments, regulatory requirements, third-party performance and other factors described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements except as required by applicable law.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much financing can Quanome access under its CEO loan agreement?

Quanome's revolving loan agreement with CEO and Chairman Yang Li provides for up to $15 million in non-dilutive growth capital. Each borrowing request requires Li's approval, and approved advances bear interest at 6.0% per annum.

How was Quanome's loan agreement with Yang Li approved?

Quanome's Board Audit Committee independently reviewed and approved the transaction, with Li excluded from its deliberations and vote. Li disclosed his interest. The committee determined that the agreement and contemplated transactions were fair and reasonable to Quanome and in, or not inconsistent with, the best interests of the company and its stockholders.